Vyant Bio, Inc.
VYNT
Revenue
46.00k
▼-106.00k▼-69.74%
3 Months ChangeAssets
15.21M
▼-7.83M▼-34.00%
3 Months ChangeLiabilities
5.30M
▼-3.90M▼-42.43%
3 Months ChangeFree Cash Flow
-4.00M
▲609.00k▲13.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-05-10
Form 8-K
ID: 0001493152-23-016068
2023-04-24
Form 8-K
ID: 0001493152-23-013369
2023-03-24
Form 8-K
ID: 0001493152-23-008809
2023-03-22
Form 8-K
ID: 0001493152-23-008488
2023-03-15
Form 8-K
ID: 0001493152-23-007670
2023-03-13
Form 8-K
ID: 0001493152-23-007350
2023-02-03
Form 8-K
ID: 0001493152-23-003456
2023-01-05
Form 8-K
ID: 0001493152-23-000445
2023-01-04
Form 8-K
ID: 0001493152-23-000322
2022-12-19
Form 8-K
ID: 0001493152-22-035914